Chest tomosynthesis may reduce the number of chest CTs and the resultant radiation doses.
Chest tomosynthesis (CTS) may be a helpful tool, optimizing chest CT resources and reducing resultant radiation doses, according to a study published in the journal Academic Radiology.
Swedish researchers performed a follow-up study of 149 patients (74 women, aged 18 to) to investigate the potential benefits and drawbacks of the clinical use of CTS, if CTS could eliminate the need for chest CT and any resultant reduction in radiation dose.
For the study, two radiologists determined if CT would have been performed had CTS not been an option, and whether CTS was an adequate examination. They then determined if CTS was beneficial, neutral or detrimental for the radiological work-up. The level of radiation used was also assessed. The subjects had undergone CTS for clinical purposes during a one-month period 3.5 years before the survey.
The results showed that CTS was beneficial in reducing the number of CTs performed. “It was judged that CT would have been performed in 100 cases, had CTS not been available, and that CTS obviated the need for CT in 80 cases,” the authors wrote. “CTS was judged as beneficial, neutral, and detrimental for the radiological work-up in 85, 13, and two cases, respectively. For the entire study population, the use of CTS decreased the average effective dose from 2.7 to 0.7 mSv.”
The researchers concluded that CTS may have benefits for the radiological work-up. The procedure has the potential to both optimize the use of CT resources and reduce the effective dose to the patient population. However, there is a drawback to the CTS examinations because they may not be able to reveal pathology that is visible with CT. For this reason, clinically doubtful cases could require further investigations, including other imaging procedures, they suggested.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.